021-51111890
购物车（）
sales@molnova.cn
Eletriptan hydrobromide
CAS No. 177834-92-3
Eletriptan hydrobromide ( UK 116044 hydrobromide )
产品货号. M12677 CAS No. 177834-92-3
Eletriptan (UK 116044) is a potent, selective, and orally active 5-HT1B/1D receptor agonist.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ￥267 | 有现货 |
|
| 5MG | ￥421 | 有现货 |
|
| 10MG | ￥518 | 有现货 |
|
| 25MG | ￥1102 | 有现货 |
|
| 50MG | ￥2001 | 有现货 |
|
| 100MG | ￥3645 | 有现货 |
|
| 200MG | ￥4739 | 有现货 |
|
| 500MG | ￥7590 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Eletriptan hydrobromide
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Eletriptan (UK 116044) is a potent, selective, and orally active 5-HT1B/1D receptor agonist.
-
产品描述Eletriptan (UK 116044) is a potent, selective, and orally active 5-HT1B/1D receptor agonist; significantly increases occluded wedge pressure and mean pulmonary artery pressure in vivo, with no significant coronary artery constriction, and obstructive coronary artery disease; displays antimigraine activity.Migrainev Approved
-
同义词UK 116044 hydrobromide
-
通路Endocrinology/Hormones
-
靶点5-HT Receptor
-
受体5-HT1B;5-HT1D
-
研究领域Neurological Disease
-
适应症Migraine
化学信息
-
CAS Number177834-92-3
-
分子量463.43
-
分子式C22H26N2O2S.HBr
-
纯度>98% (HPLC)
-
溶解度DMSO: 46.3 mg/mL (100 mM) （ < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESCN1CCC[C@@H]1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br
-
化学全称3-[[(2R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole hydrobromide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Napier C, et al. Eur J Pharmacol. 1999 Mar 5;368(2-3):259-68.
2. Gupta P, et al. Eur J Pharmacol. 1999 Feb 19;367(2-3):283-90.
3. Muir DF, et al. Clin Pharmacol Ther. 1999 Jul;66(1):85-90.
2. Gupta P, et al. Eur J Pharmacol. 1999 Feb 19;367(2-3):283-90.
3. Muir DF, et al. Clin Pharmacol Ther. 1999 Jul;66(1):85-90.
产品手册
关联产品
-
PF-05212377
PF-05212377 (SAM-760, PF 5212377) is a potent and selective 5-HT6 receptor antagonist with potential therapy for the symptomatic treatment of mild to moderate Alzheimer's disease.
-
Mirtazapine
Mirtazapine is an antidepressant introduced by Organon International in 1996 used for the treatment of moderate to severe depression.
-
Revexepride
Revexepride (SSP 002358;SPD-557) potent, highly selective 5-HT4 receptor agonist for the treatment of gastroesophageal reflux disease.
